Biotech · Private company
Olatec Therapeutics, Inc.
Track this companyFree. Adds Olatec Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials42 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- DapansutrilePhase 3 · Acute Gout FlareClinicalTrials.gov · fetched Nov 12, 2026
- dapansutrile capsulesPhase 2 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
- dapansutrile capsulesPhase 1 · Systolic Heart FailureClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Study of Dapansutrile Tablets in Subjects With an Acute Gout FlarePHASE2_PHASE3 · RECRUITING · started Jan 6, 2023ClinicalTrials.gov NCT05658575 · fetched Nov 12, 2026
- A Study of Dapansutrile Plus Pembrolizumab in Patients With PD-1 Refractory Advanced MelanomaPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Sep 6, 2022ClinicalTrials.gov NCT04971499 · fetched Nov 12, 2026
- Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release SyndromePHASE2 · TERMINATED · started Sep 24, 2020ClinicalTrials.gov NCT04540120 · fetched Nov 12, 2026
- Study of Dapansutrile Capsules in Heart FailurePHASE1 · COMPLETED · started May 16, 2018ClinicalTrials.gov NCT03534297 · fetched Nov 12, 2026